Buspirone Treatment of Anxiety in Williams Syndrome

NCT04807517 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Williams Syndrome
Anxiety

Interventions

DRUG: Buspirone

Sponsor

Massachusetts General Hospital